Yan, R., Zhu, H., Lu, J., Teng, G. (2025). Concurrent transarterial chemoembolization plus atezolizumab and bevacizumab in unresectable hepatocellular carcinoma: Interim analysis from a multicenter real-world study (CHANCE 023).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.542